XML 26 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements Of Cash Flows (USD $)
In Millions, unless otherwise specified
 12 Months Ended
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2009
Cash flows from operating activities:      
Net income (loss) $ 295.0 $ 63.8 $ (38.1)
Depreciation and amortization 63.8 62.1 67.4
Gain on sale of business     (6.3)
Litigation settlement gains     (11.1)
Accrued litigation settlement and contract termination   33.3  
Litigation settlement payments   (19.0)  
Loss on prepayment of debt, net 3.1    
Call premium paid (2.5)    
Assets held for sale write-down 1.1 0.5 0.7
Securities transactions, net 0.6 (0.3) (0.5)
Loss on disposal of property and equipment 0.9 1.8 1.2
Noncash interest expense 5.5 2.4 2.0
Benefit plan expense greater (less) than cash funding requirements:      
Defined benefit pension expense 0.4 (1.3) 0.3
Other postretirement benefit expense (1.8) 0.3 0.4
Deferred income taxes 95.3 (11.1) (21.9)
Equity in joint venture earnings 0.5 0.4 1.1
Net distributions from TiO2 manufacturing joint venture 3.8 2.4 7.7
Other, net 1.3 2.2 3.5
Change in assets and liabilities:      
Accounts and other receivables, net (47.9) (53.4) 6.0
Inventories, net (184.3) 4.6 105.2
Accounts payable and accrued liabilities 96.1 (15.1) 4.3
Income taxes 19.8 9.5 (3.0)
Accounts with affiliates (36.6) 21.4 (18.1)
Other noncurrent assets (3.3) 0.2 0.3
Other noncurrent liabilities (13.2) 7.4 (9.5)
Other, net (5.2) 10.1 (15.6)
Net cash provided by operating activities 292.4 122.2 76.0
Cash flows from investing activities:      
Capital expenditures (146.2) (44.7) (57.5)
Capitalized permit costs (8.9) (5.8) (9.4)
Acquisition, net of cash acquired (4.8)    
Purchases of:      
Mutual funds (272.8)    
Titanium Metals Corporation ("TIMET") common stock (30.4) (43.5)  
Other marketable securities (6.9) (11.5) (5.4)
Proceeds from:      
Disposal of mutual funds 251.0    
Disposal of other marketable securities 5.0 7.6 9.5
Disposal of restricted marketable securities   5.2  
Sale of business 0.3 0.5 6.7
Real estate-related litigation settlement     11.8
Collection of real-estate related note receivable 15.0    
Loan to affiliate (11.2)    
Change in restricted cash equivalents, net (3.0) (0.4) 0.5
Other, net (8.0) (0.5) (0.7)
Net cash used in investing activities (220.9) (93.1) (44.5)
Cash flows from financing activities:      
Borrowings 121.3 497.5 447.6
Principal payments (328.8) (537.3) (401.1)
Deferred financing costs paid (0.1) (0.8) (0.8)
Lease deposit held for loan repayment   (6.2)  
Purchases of Kronos common stock     (0.1)
Valhi cash dividends paid (53.7) (45.5) (45.4)
Distributions to noncontrolling interest in subsidiaries (29.3) (7.8) (4.9)
Treasury stock acquired (9.5) (2.0)  
Purchase of noncontrolling interest in subsidiary   (7.0)  
Issuance of subsidiary common stock   337.6  
Issuance of Valhi common stock and other, net 0.3 0.1  
Net cash provided by (used in) financing activities (299.8) 228.6 (4.7)
Cash and cash equivalents - net change from:      
Operating, investing and financing activities (228.3) 257.7 26.8
Effect of exchange rates on cash (0.4) (1.3) 4.9
Net change for the year (228.7) 256.4 31.7
Balance at beginning of year 325.1 68.7 37.0
Balance at end of year 96.4 325.1 68.7
Cash paid (received) for:      
Interest, net of amounts capitalized (including call premium paid) 67.0 64.5 64.8
Income taxes, net 73.8 (6.2) 6.4
Noncash investing activities:      
Accruals for capital expenditures 23.5 11.6 11.8
Accruals for capitalized permits 0.7 1.1 1.2
Note receivable from sale of business     0.8
Noncash financing activities:      
Promissory note issued in connection with litigation settlement   18.0  
Promissory note issued in connection with contract termination   12.0  
Accrued construction retainage payable converted into note payable   5.8  
Transfer of Medite pension plan to Contran     $ 4.3